葡聚糖微球栓塞子宫动脉治疗子宫腺肌病的临床应用  

Dextran microspheres embolization uterine artery for Treatment of Adenomyosis

作　　者：曲宏伟[1] 刘兵元[2] 马新文[2] 马静[2] 彭栋[3] 赵新建[2] 

机构地区：[1]石河子大学医学院 [2]石河子大学医学院第一附属医院放射科,新疆石河子832008 [3]新疆昌吉州人民医院放射科,新疆昌吉831100

出　　处：《农垦医学》2009年第3期213-217,共5页Journal of Nongken Medicine

摘　　要：目的:探讨葡聚糖微球栓塞子宫动脉治疗子宫腺肌病的近期临床疗效。方法:对30例子宫腺肌病患者进行子宫动脉栓塞治疗,UAE术前及术后1、3、6月随访观察痛经程度、子宫体积缩小程度、月经量的变化情况。结果:30例患者行双侧子宫动脉栓塞,27例患者(90.00%)症状有不同程度的缓解,其中痛经缓解最为显著。行UAE后1月、3月、6月彩超复查子宫体积平均缩小率分别为14.56%、36.63%、41.32%。结论:葡聚糖微球栓塞子宫动脉治疗子宫腺肌病,近期疗效显著,且无严重并发症发生,是一种科学、微创、安全、有效的治疗方法。Objective： To evaluate the effects of dextran mierospheres uterine artery embolization for adenomyosis. Methods： Total of 30 patients with adenomyosis were treated by UAE. They were followed for 1,3 and 6 months to be observed for The improvement of symptoms and uterine size changes. Results： Bilateral embolization of the uterine arteries was performed in 30 patients , Improvement of menstrual pain was obtained in 27（90. 0 0% ） symptomatic patients. The mean reduction of uterine volume was 14.56% ,36.63% ,41.32%, respectively at 6 months after embolization. Conclusion：This shows uterine artery embolization with Dextran mierospheres is an effective in the near future .

关 键 词：子宫腺肌病 介入治疗 栓塞 葡聚糖微球 

分 类 号：R711.73[医药卫生—妇产科学]